SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

That would be logical once the anecdotal reports

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
vidpok45 Member Profile
 
Followed By 22
Posts 4,872
Boards Moderated 0
Alias Born 06/15/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/8/2016 8:01:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/7/2016 4:07:44 PM
ARIAD’s Investigational Medicine Brigatinib Demonstrated 15.6 Month Systemic Median Progression-Free Survival in ALTA Study "Business Wire" - 12/7/2016 7:35:00 AM
ARIAD Announces Data Presentations at American Society of Hematology Meeting "Business Wire" - 12/6/2016 7:35:00 AM
ARIAD Presents Updated Brigatinib Data with 18.4 Months Median Intracranial Progression Free Survival (PFS) in ALK+ NSCLC Pat... "Business Wire" - 12/5/2016 7:35:00 AM
ARIAD to Host Webcast and Conference Call on Brigatinib Data Presentations at the World Conference on Lung Cancer "Business Wire" - 12/2/2016 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/30/2016 4:06:56 PM
ARIAD Announces FDA Full Approval & Label Update for Iclusig® (ponatinib) Based on Long-Term Efficacy & Safety Data from Pha... "Business Wire" - 11/29/2016 7:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/18/2016 4:07:44 PM
ARIAD Announces Data Presentations at the World Conference on Lung Cancer "Business Wire" - 11/16/2016 5:04:00 PM
ARIAD Announces Launch of Inaugural ALK+ Day During Lung Cancer Awareness Month "Business Wire" - 11/14/2016 7:35:00 AM
ARIAD Announces Phase 1/2 Trial Data on Investigational Drug Brigatinib Published in The Lancet Oncology "Business Wire" - 11/9/2016 7:35:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2016 5:34:45 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2016 7:41:24 AM
ARIAD Reports Third Quarter 2016 Financial Results "Business Wire" - 11/7/2016 7:35:00 AM
ARIAD to Present at the Jefferies 2016 London Healthcare Conference "Business Wire" - 11/2/2016 7:35:00 AM
ARIAD to Webcast Conference Call on Third Quarter 2016 Financial Results "Business Wire" - 11/1/2016 7:35:00 AM
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib "Business Wire" - 10/31/2016 7:35:00 AM
Goldberg Law PC Announces an Investigation of Ariad Pharmaceuticals Inc. & Advises Investors with Losses t... "Business Wire" - 10/28/2016 1:42:00 PM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ariad Pharmaceuticals Inc. Investors "Business Wire" - 10/28/2016 12:33:00 PM
ARIAD Announces Publication of the Preclinical Profile of Brigatinib in the Journal Clinical Cancer Research "Business Wire" - 10/26/2016 7:35:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/25/2016 4:09:31 PM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 10/21/2016 9:39:00 AM
ARIAD Reaffirms Commitment to Discovering and Developing Treatments for Patients with Rare Cancers "Business Wire" - 10/20/2016 4:21:00 PM
ARIAD Presents Updated Long-Term Follow-up Results from the Phase 1/2 Trial on Investigational Drug Brigatinib at 2016 ESMO M... "Business Wire" - 10/10/2016 7:35:00 AM
vidpok45   Tuesday, 05/15/12 08:11:15 PM
Re: ariadndndough post# 18930
Post # of 79586 
That would be logical once the anecdotal reports can be validated.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist